SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-16-018639
Filing Date
2016-11-16
Accepted
2016-11-16 07:36:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D sc13da31116canfite_opthalix.htm SC 13D/A 23428
  Complete submission text file 0001213900-16-018639.txt   25099
Mailing Address 10 BAREKET STREET PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET PETACH TIKVA L3 4951778 972 3 9241114
OphthaliX, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82946 | Film No.: 162001336
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filed by) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations